Comparing Biologic Factor Composition of Birth Tissue-Derived Allografts and Platelet-Rich Plasma

Background Orthobiologic products are used for their regenerative potential, but variability in their composition may impact clinical outcomes. This study examined differences in key biologic factors among various products and preparation methods. Methodology Different formulations of platelet-rich plasma (PRP) and birth tissue-derived allografts were analyzed for specific biologic factors using laboratory assays. Results PRP demonstrated consistent biologic factor levels across samples, while allograft products exhibited notable variability. One category of birth tissue-derived products contained higher levels of a specific growth factor compared to others. Conclusions PRP showed greater consistency compared to allografts, which varied significantly between product lots. Standardization may improve the reliability of orthobiologic therapies.